Vivos Therapeutics Inc VVOS shares are trading lower by 9.57% to $1.70 Thursday morning after the company priced an $8 million private placement at $1.20 per unit.
Vivos Therapeutics says, after the placement agent fees and estimated offering expenses payable by the company, Vivos expects to receive net proceeds of approximately $7.5 million.
The offering is expected to close on January 9, subject to customary closing conditions.
See Also: What's Going On With Apple Stock Today?
According to data from Benzinga Pro, VVOS has a 52-week high of $3.69 and a 52-week low of $0.34.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
